Document:

exv10w1

Exhibit 10.1

AMENDMENT NO. 3 TO THE COMPANY’S MANAGEMENT STOCK PURCHASE PLAN

RECITALS:

     WHEREAS, LifePoint Hospitals, Inc. (the “Company”) established the LifePoint Hospitals, Inc.
Management Stock Purchase Plan (the “Plan”) effective May 11, 1999, in order to encourage equity
ownership in the Company among its executives and to align the financial interests of such
executives and the Company’s stockholders;

     WHEREAS, the Plan was (i) amended and restated effective December 16, 2002, without the need
for approval from the Company’s stockholders, (ii) amended with approval of the Company’s
stockholders, effective May 13, 2008, to increase the number of shares of the Company’s stock
available for issuance under the Plan, and (iii) amended, effective January 1, 2009, to comply with
Treasury Regulations promulgated under Section 409A of the Internal Revenue Code without the need
for approval from the Company’s stockholders;

     WHEREAS, the Plan provides for a ten year term;

     WHEREAS, Section 12 of the Plan provides that the board of directors of the Company may amend
the Plan at any time, subject to the approval of the Company’s stockholders where necessary;

     WHEREAS, the board of directors of the Company has authorized the amendment of the Plan to
extend its term indefinitely, provided that the Company shall not make new grants under the Plan
after May 11, 2009 unless such grants are approved by the Company’s stockholders; and

     WHEREAS, the Company intends to seek approval for continued grants under the Plan throughout
the Plan’s term, as extended by this amendment, at its annual meeting on May 12, 2009;

     NOW, THEREFORE, the Plan is hereby amended by restating Section 13 of the Plan in its entirety
as follows:

     13. Term of the Plan.

     The Plan shall remain in effect until such time that it is terminated by the
Board; provided, however, that no Restricted Shares may be granted and no Restricted
Share Units may be credited to Participants under the Plan after May 11, 2009,
unless approval for such action is given by the Company’s stockholders at the
Company’s 2009 annual meeting. If such approval is attained at the Company’s 2009
annual meeting, Restricted Shares may be granted and Restricted Share Units may be
credited under the Plan, in accordance with the Plan’s terms, until such time that
additional approval from the Company’s stockholders would be required under any law,
regulation or stock exchange requirement. Notwithstanding the foregoing, neither
termination of the Plan nor failure to receive approval from the Company’s
stockholders at the Company’s 2009 annual meeting shall, without the consent of any
Participant who then holds Purchased Shares or to whom Purchased Share Units are
then credited, alter or impair any rights or obligations in respect of such
Purchased Shares or Purchased Share Units.

     IN WITNESS WHEREOF, the undersigned officer of the Company has executed this Amendment on this
the 24th day of March, 2009.

	 	 	 	 	 	 	 
	 

	 	 	 	LIFEPOINT HOSPITALS, INC.	 	 
	 

	 	By:	 	/s/ John P. Bumpus	 	 
	 

	 	 	 	 

	 	 
	 

	 	Its:	 	EVP and Chief Administrative Officerexv10w2

Exhibit 10.2

AMENDMENT TO THE COMPANY’S OUTSIDE DIRECTORS STOCK

AND INCENTIVE COMPENSATION PLAN

RECITALS:

     WHEREAS, LifePoint Hospitals, Inc. (the “Company”) established the LifePoint Hospitals, Inc.
Outside Directors Stock and Incentive Compensation Plan (the “Plan”) effective May 11, 1999 in
order to encourage equity ownership in the Company among its executives and to align the financial
interests of such executives and the Company’s stockholders;

     WHEREAS, the Company amended and restated the Plan effective May 14, 2008, without the need
for approval from the Company’s stockholders

     WHEREAS, the Plan provides for a ten year term;

     WHEREAS, Section 14 of the Plan provides that the board of directors of the Company may amend
the Plan at any time, subject to the approval of the Company’s stockholders where necessary;

     WHEREAS, the board of directors of the Company has authorized the amendment of the Plan to
extend its term indefinitely, provided that the Company shall not grant new awards under the Plan
following the effective date of this amendment unless such grants are approved by the Company’s
stockholders; and

     WHEREAS, the Company intends to seek approval for continued grants under the Plan throughout
the Plan’s term, as extended by this amendment, at its annual meeting on May 12, 2009;

     NOW, THEREFORE, the Plan is hereby amended by restating Section 15 of the Plan in its entirety
as follows:

     15. Term of the Plan.

     The Plan shall remain in effect until such time that it is terminated by the
Board; provided, however, that no new Awards may be made under the Plan unless
approval for such action is given by the Company’s stockholders at the Company’s
2009 annual meeting. If such approval is attained at the Company’s 2009 annual
meeting, Awards may be made under the Plan, in accordance with the Plan’s terms,
until such time that additional approval from the Company’s stockholders would be
required under any law, regulation or stock exchange requirement. Notwithstanding
the foregoing, neither termination of the Plan nor failure to receive approval from
the Company’s stockholders at the Company’s 2009 annual meeting shall, without the
consent of any Participant who then holds an Award, alter or impair any rights or
obligations in respect of such Award.

     IN WITNESS WHEREOF, the undersigned officer of the Company has executed this Amendment on this
the 24th day of March, 2009.

	 	 	 	 	 	 	 
	 

	 	 	 	LIFEPOINT HOSPITALS, INC.	 	 
	 

	 	By:	 	/s/ John P. Bumpus	 	 
	 

	 	 	 	 

	 	 
	 

	 	Its:	 	EVP and Chief Administrative Officerexv10w1

EXHIBIT 10.1

CONFIDENTIALITY, NON-COMPETITION

AND NON-SOLICITATION EMPLOYMENT AGREEMENT –

ZIMMER OPERATING COMMITTEE MEMBERS

     This Confidentiality, Non-Competition and Non-Solicitation Employment Agreement (this
“Agreement”) is made by and between Zimmer, Inc. (“Company”) and                                         
(“Employee”).

Recitals

     A. For purposes of this Agreement, “Parent” means an entity which is a holding company of or
holds a controlling interest in Company; “Affiliates” means a subsidiary of Company or the Parent
of Company or a company over which Company or any holding company of Company has control; and the
definition of each of Company, Parent and Affiliates, includes any of their successors-in-interest.
References herein to Company shall be deemed to include any Parents or Affiliates.

     B. Company, Parent and the Affiliates are part of the global holdings of Zimmer Holdings,
Inc., a publicly traded corporation incorporated under the laws of the state of Delaware, U.S.A.,
the primary purpose of which is to serve as the umbrella entity for Company. Company, Parent and
the rest of the Affiliates located throughout the world are engaged in the highly competitive
business of the development, manufacture, distribution, and sale of orthopaedic medical, oral
rehabilitation and/or spine or trauma devices, products, and services.

Agreement

     NOW, THEREFORE, in consideration of the foregoing recitals, Company’s employment of Employee,
the grant of equity-based awards to Employee under an equity incentive plan of Zimmer Holdings,
Inc., including the grant of stock options, restricted stock and/or restricted stock units, and the
promises and covenants contained in this Agreement, the sufficiency of which is hereby
acknowledged, and intending to be legally bound hereby, Company and Employee agree as follows:

     1. Acknowledgements. Employee acknowledges that Company is engaged in the highly
competitive business of the development, manufacture, distribution, and sale of orthopaedic
medical, oral rehabilitation and/or spine or trauma devices, products, and services. Employee
acknowledges that Employee has significant responsibility for Company’s overall competitive
position and business strategy as related to its operations worldwide. Further, Employee
acknowledges that in the course of Employee’s employment with Company, Employee i) has been given
and will continue to be given access to trade secrets and other Confidential Information (as
hereinafter defined) related to all aspects of Company management; ii) has participated and will
continue to participate in the development of, execution of, and/or usage of inventions, products,
concepts, strategies, methods, or technologies which are related to Company’s business; iii) has
been given and will continue to be given specialized training relating to Company’s products and/or
processes; and/or iv) has been given and will continue to be given access to Company’s customers
and other business relationships.

 

 

     2. Termination of Employment. Company and Employee acknowledge and agree that
Employee’s employment is on an at-will basis, and, accordingly, either Company or Employee may
terminate the employment relationship at any time for any reason, or no reason whatsoever, with or
without cause, and without advance notice.

     3. Non-Disclosure of Confidential Information. Employee acknowledges that
Confidential Information is a valuable, special, and unique asset of Company, Parent, and the
Affiliates, and agrees to the following:

     (a) Confidential Information Defined. The term “Confidential Information”
includes, but is not limited to, any and all of Company’s, Parent’s or Affiliates’ trade
secrets, confidential and proprietary information and all other information and data of
Company that is not generally known to the public or other third parties who could derive
economic value from its use or disclosure. Confidential Information includes, without
limitation, the following: i) marketing, sales, and advertising information such as lists
of actual or potential customers; customer preference data; marketing and sales techniques,
strategies, efforts, and data; merchandising systems and plans; confidential customer
information including identification of purchasing personnel, account status, needs and
ability to pay; business plans; product development and delivery schedules; market research
and forecasts; marketing and advertising plans, techniques, and budgets; overall pricing
strategies; the specific advertising programs and strategies utilized, and the success or
lack of success of those programs and strategies; ii) organizational information such as
personnel and salary data; merger, acquisition and expansion information; information
concerning methods of operation; divestiture information; and competitive information
pertaining to Company’s distributors; iii) financial information such as product costs;
supplier information; overhead costs; profit margins; banking and financing information; and
pricing policy practices; iv) technical information such as product specifications,
compounds, formulas, improvements, discoveries, developments, designs, inventions,
techniques, new products and surgical training methods; v) information disclosed to Employee
as part of a training process; and vi) information of third parties provided to Employee
subject to non-disclosure restrictions for use in Employee’s business for Company.
Confidential Information also includes any work product created by Employee in rendering
services for Company.

     (b) Non-Disclosure of Confidential Information. During Employee’s employment
with Company and thereafter, Employee will not disclose, transfer, or use (or seek to induce
others to disclose, transfer, or use) any Confidential Information for any purpose other
than i) disclosure to authorized employees and agents of Company who are bound to maintain
the confidentiality of the Confidential Information; and/or ii) for authorized purposes
during the course of Employee’s employment in furtherance of Company’s business. Employee’s
non-disclosure obligations shall continue as long as the Confidential Information remains
confidential and shall not apply to information that becomes generally known to the public
through no fault or action of Employee or others who were under non-disclosure obligations
as to such information.

     (c) Protection of Confidential Information. Employee will notify Company in
writing of any circumstances which may constitute unauthorized disclosure, transfer, or

-2-

 

use of Confidential Information. Employee will use Employee’s best efforts to protect
Confidential Information from unauthorized disclosure, transfer, or use. Employee will
implement and abide by all procedures adopted by Company to prevent unauthorized disclosure,
transfer, or use of Confidential Information.

     4. Ownership of Confidential Information and Inventions.

     (a) Invention Defined. The term “Invention” includes, but is not limited to
ideas, programs, processes, systems, intellectual property, works of authorship,
copyrightable materials, discoveries, and/or improvements of which Employee conceives alone
or in conjunction with others during Employee’s employment with Company and/or within six
(6) months after Employee’s employment ends which relate to Company’s present or future
business. An Invention is covered by this Agreement regardless of whether i) Employee
conceived of the Invention in the scope of Employee’s employment; or ii) the Invention is
patentable.

     (b) Ownership of Confidential Information and Inventions. Confidential
Information and Inventions are solely the property of Company. Employee agrees that
Employee does not have any rights, title, or interest in any of the Confidential Information
or Inventions. Nonetheless, Employee may be recognized as the inventor of an Invention
without retaining any other rights associated therewith.

     (c) Disclosure and Assignment of Inventions. Employee hereby assigns to
Company all right, title and interest Employee may have in any Inventions that are
developed, made, authored, or conceived by Employee (whether alone or with others) during
Employee’s employment with Company. Employee agrees to: (i) promptly disclose all such
Inventions in writing to Company; (ii) keep complete and accurate records of all such
Inventions, which records shall be Company property and shall be retained on Company
premises; and (iii) execute such documents and do such other acts as may be necessary in the
opinion of Company to establish and preserve Company’s property rights in all such
Inventions. This section shall not apply to any Invention for which no equipment, supplies,
facility or trade secret information of Company was used and which was developed entirely on
Employee’s own time, and (1) which does not relate (a) directly to the business of Company
or (b) to Company’s actual or demonstrably anticipated research or development, or (2) which
does not result from any work performed by Employee for Company.

     5. Return of Confidential Information and Company Property. Immediately upon
termination of Employee’s employment with Company, Employee shall return to Company all of
Company’s property relating to Company’s business, including without limitation all of Company’s
property which is in the possession, custody, or control of Employee such as Confidential
Information, documents, hard copy files, copies of documents and electronic information/files.

     6. Obligations to Other Entities or Persons. Employee warrants that Employee is not
bound by the terms of a confidentiality agreement or any other legal obligation which would either
preclude or limit Employee from disclosing or using any of Employee’s ideas, inventions,

-3-

 

discoveries or other information or otherwise fulfilling Employee’s obligations to Company.
While employed by Company, Employee shall not disclose or use any confidential information
belonging to another entity or other person.

     7. Conflict of Interest and Duty of Loyalty. During Employee’s employment with
Company, Employee shall not engage, directly or indirectly, in any activity, employment or business
venture, whether or not for remuneration, that i) is competitive with Company’s business; ii)
deprives or potentially could deprive Company of any business opportunity; iii) conflicts or
potentially could conflict with Company’s business interests; or iv) is otherwise detrimental to
Company, including but not limited to preparations to engage in any of the foregoing activities.

     8. Non-Competition Covenants. Company and Employee acknowledge and agree that the
following non-competition covenants are reasonable and necessary to protect the legitimate
interests of Company, Parent and Affiliates, including, without limitation, the protection of
Confidential Information, Inventions and goodwill. Employee agrees to, and covenants to comply
with, each of the following separate and divisible restrictions:

     (a) Definitions.

     (1) “Competing Product” is defined as (a) any orthopaedic implant, product,
process, or service; any dental reconstructive implant, product, or service; any
spine implant, product, process or service; any trauma product or service; or any
other product or service, in each case that is similar to (or would serve as a
substitute for) and competitive with any orthopaedic implant, product, process, or
service; any dental reconstructure implant, product, process, or service; any spine
implant, product, process, or service; or any trauma product or service; or any
other product or service, in each case that Company, Parent and/or Affiliate is
researching, developing, manufacturing, distributing, selling and/or providing at
the time of Employee’s termination of employment with Company and which Employee
worked in conjunction with or obtained any trade secret or other Confidential
Information about at any time during the two years immediately preceding the
termination of Employee’s employment with Company; and/or (b) any product or service
that is similar to (or would serve as a substitute for) and competitive with any
product or service that Company, Parent and/or Affiliate is researching, developing,
manufacturing, distributing, selling and/or providing at the time of termination of
Employee’s employment with Company and which Employee worked in conjunction with or
obtained any trade secret or other Confidential Information about at any time during
the two years immediately preceding the termination of Employee’s employment with
Company.

     (2) “Competing Organization” is defined as any organization that researches,
develops, manufactures, markets, distributes and/or sells one or more Competing
Products or has plans to research, develop, manufacture, market, distribute, and/or
sell one or more Competing Products. A Competing Organization is diversified
(“Diversified Competing Organization”) if (a) it

-4-

 

controls or is in common control of entities which conduct business in an
industry other than the orthopaedic products industry or the dental reconstructive,
spine implant or trauma products industries, or (b) operates multiple business
divisions, units, lines or segments some of which do not involve any Competing
Products.

     (3) “Prohibited Capacity” is defined as: i) the same or similar capacity or
function in which the Employee worked for Company at any time during the last two
years of Employee’s employment; ii) any executive or managerial capacity; iii) any
sales or sales management capacity; and/or iv) any other capacity in which
Employee’s knowledge of Confidential Information and/or Inventions would render
Employee’s assistance to a Competing Organization a competitive advantage.

     (4) “Restricted Geographic Area” is defined as the following: i) the
continental United States; ii) Canada; iii) Latin America; iv) Asia/Australia; v)
all countries of the European Union; vi) Switzerland; and vii) all other countries,
territories, or states in which Company is doing business or is selling its products
at the time of termination of Employee’s employment with Company.

     (5) “Non-Competition Period” is defined as the date Employee executes this
Agreement, continuing through the eighteen (18) months after the Employee’s last day
of employment with Company unless otherwise extended by Employee’s breach of this
Agreement.

     (6) “Customer” is defined as any distributor, health care dealer, hospital,
hospital system, university practitioner, surgeon, dentist, health care purchasing
organization, surgical group, person or entity, in each case with respect to whom,
as of the termination of Employee’s employment with Company or at any time during
the two years prior to such employment termination, Company directly or indirectly
sold or provided any products and/or services.

     (7) “Active Prospect” is defined as any person or entity that Employee
identified, marketed to, and/or held discussions with regarding the research,
development, manufacture, distribution, and/or sale of any of Company’s products or
services at any time during the last twelve (12) months of Employee’s employment
with Company, and/or any person or entity that Company identified, marketed to,
and/or held discussions with regarding the research, development, manufacture,
distribution, and/or sale of any of Company’s products or services at any time
during the last twelve (12) months of Employee’s employment with Company.

     (b) Restrictive Covenants. During the Non-Competition Period, Employee agrees
to be bound by each of the following independent and divisible restrictions:

     (1) Employee will not, within the Restricted Geographic Area, be employed by,
work for, consult with, provide services to, or lend assistance to any Competing
Organization in a Prohibited Capacity.

-5-

 

     (2) Employee will not be employed by, work for, consult with, provide services
to, or lend assistance to any Competing Organization in any capacity if it is likely
that as part of such capacity, Employee would inevitably use and/or disclose any of
Company’s trade secrets or other Confidential Information.

     (3) Employee may be employed by, work for, consult with, provide services to,
or lend assistance to any Diversified Competing Organization provided that: i) the
part of the Competing Organization’s diversified business with which Employee will
be affiliated does not involve any Competing Products; ii) the Employee’s
affiliation with the Competing Organization does not involve any Competing Products;
iii) Employee provides Company with a written description of Employee’s anticipated
activities on behalf of the Competing Organization which includes, without
limitation, an assurance satisfactory to Company that Employee’s affiliation with
the Competing Organization does not involve any Competing Products; iv) Employee’s
affiliation with the Competing Organization would not likely cause Employee to
inevitably use and/or disclose any of Company’s trade secrets or other Confidential
Information; and v) Employee’s affiliation with the Diversified Competing
Organization does not constitute a competitive disadvantage to the Company.

     (4) Employee will not be employed by, work for, consult with, provide services
to or lend assistance to any Customers or Active Prospects in the Restricted
Geographic Area in a capacity or role that involves any Competing Products and is
competitive with the business of Company.

     (5) Employee will not provide, sell, market, assist in the provision, selling
or marketing of, or attempt to provide, sell or market any Competing Products to any
of Company’s Customers located in the Restricted Geographic Area or otherwise
solicit or communicate with any of Company’s Customers located in the Restricted
Geographic Area for the purpose of selling, marketing or providing, assisting in the
provision, selling or marketing of, or attempting to sell, market or provide any
Competing Products.

     (6) Employee will not provide, sell, market, attempt to provide, sell or
market, or assist any person or entity in the sale or provision of, any Competing
Products to any of Company’s Customers with respect to whom, at any time during the
two years immediately preceding the termination of Employee’s employment with
Company, Employee had any sales or service contact on behalf of Company, Employee
had any business contact on behalf of Company, Employee had any sales or service
responsibility (including without limitation any supervisory or managerial
responsibility) on behalf of Company, or Employee had access to, or gained knowledge
of, any Confidential Information concerning Company’s business with such customer,
or otherwise solicit or communicate with any such customers for the purposes of
selling or providing any Competing Products.

-6-

 

     (7) Employee will not provide, sell, market, attempt to provide, sell or market, or assist any person or entity in the sale or provision of, any
Competing Products to any of Company’s Active Prospects, or otherwise solicit or
communicate with any of Company’s Active Prospects for the purpose of selling or
providing any Competing Products.

     (8) Employee will not urge, induce or seek to induce any of Company’s
independent contractors, subcontractors, distributors, brokers, consultants, sales
representatives, customers, vendors, suppliers or any other person or entity with
whom Company has a business relationship to terminate their relationship with, or
representation of, Company or to cancel, withdraw, reduce, limit or in any manner
modify any such person’s or entity’s business with, or representation of, Company.

     (9) Employee will not solicit, recruit, hire, employ, engage or retain, or
assist any Competing Organization in the solicitation, recruitment, hiring,
employment, engagement or retention of, any of Company’s distributors, sales
representatives, or consultants located in the Restricted Geographic Area, for any
competitive purpose.

     (10) Employee will not employ, engage in personal service or favor (whether or
not compensated), solicit for employment, advise or recommend to any other person or
entity that such person or entity employ, or solicit for employment, any individual
now or hereafter employed by Company, or otherwise induce or entice any such
employee to leave his/her employment with Company to work for, consult with, provide
services to, or lend assistance to any Competing Organization.

     (11) Employee will not make or publish any disparaging or derogatory statements
about Company, its products, Parent and any of the Affiliates, together with their
past, present and future officers, directors, employees, attorneys and agents.
Disparaging or derogatory statements include, but are not limited to, negative
statements regarding Company’s business or other practices; provided, however,
nothing herein shall prohibit Employee from providing any information as may be
compelled by law or legal process.

     (12) Employee agrees that the divisible covenants contained in this Agreement
prohibit Employee from engaging in the restricted activities directly or indirectly,
whether on Employee’s behalf or on behalf of or for the benefit of any other person
or entity, including for Employee’s benefit, and that all of the covenants restrict
Employee from engaging in activities for a competitive purpose.

     (13) The Non-Competition Period shall not expire during any period in which
Employee is in violation of any of the restrictive covenants set forth herein, and
all restrictions shall automatically be extended by the period Employee was in
violation of any such restrictions.

-7-

 

     9. Reasonableness of Terms. Employee acknowledges and agrees that the restrictive
covenants contained in this Agreement are reasonably necessary to protect Company’s, Parent’s and
Affiliates’ legitimate interests in Confidential Information, Inventions, and goodwill.
Additionally, Employee acknowledges and agrees that the restrictive covenants are reasonable in all
respects, including, but not limited to, temporal duration, scope of prohibited activities and
geographic area. Employee further acknowledges and agrees that the restrictive covenants set forth
in this Agreement will not pose any hardship on Employee and that Employee will reasonably be able
to earn an equivalent livelihood without violating any provision of this Agreement.

     10. Non-Competition Period Payments. To the extent Employee is denied a specific
employment position with a Competing Organization solely because of the restrictive covenant
provisions of Section 8 of this Agreement, and provided Employee satisfies all conditions stated
herein, then upon expiration of the total cumulative period of time represented by both any
severance benefits which Employee is otherwise eligible to receive and any compensation paid to
Employee pursuant to a change in control agreement, Company will make payments to Employee equal to
Employee’s monthly base pay as was in effect at the time of termination of Employee’s employment
(exclusive of extra compensation and any other employee benefits) for each month of such
unemployment through the end of the Non-Competition Period. Severance benefits and change of
control payments shall be deemed to have expired at the conclusion of the period of time
represented by the total amount of any such benefits paid. For example, if Employee were to
receive basic and supplemental severance in an amount equal to twenty (20) weeks of Employee’s
final base pay, and a change of control payment in an amount equal to twenty (20) weeks of
Employee’s final base pay, Employee would not be eligible to begin receiving Non-Competition Period
Payments until the forty-first (41st) week following Employee’s termination of
employment with Company, regardless of the timing of the severance and change in control payments.
If Employee is denied a specific employment position with a Competing Organization solely because
of the restrictive covenant provisions of Section 8 of this Agreement but obtains replacement
employment that does not violate Section 8 of this Agreement, and the monthly compensation
(including base pay, commissions, incentive compensation, bonuses and other compensation) for the
replacement employment is less than Employee’s monthly base pay as was in effect at the time of the
termination of Employee’s employment with the Company, Company agrees to pay Employee the
difference for each such month through the end of the Non-Competition Period, again upon expiration
of any severance benefits and change in control payments which Employee is otherwise eligible to
receive and provided Employee satisfies all conditions stated herein. To qualify for payments
under this Section 10, Employee must provide Company detailed written documentation supporting
eligibility for payment, including, at a minimum, (a) the name and location of the Competing
Organization that would have employed Employee but for the provisions of Section 8 of this
Agreement, (b) the title, nature, and detailed job responsibilities of the employment position with
the Competing Organization that Employee was denied because of the provisions of Section 8 of this
Agreement, (c) the date Employee was denied the employment position because of the provisions of
Section 8 of this Agreement, and (d) the name and contact information of a managerial employee at
the Competing Organization who has sufficient authority to confirm that Employee was denied this
specific employment position with the Competing Organization solely because Employee is subject to
the provisions of Section 8 of this Agreement (the “eligibility documentation”). Upon
receipt of the eligibility documentation,

-8-

 

Company will determine eligibility for payment and, if eligibility is established, payments
will commence as of the date of Company’s receipt of the eligibility documentation. Employee is
obligated to diligently seek and pursue replacement employment during any period in which Employee
seeks payment from Company under this Section 10. After eligibility is established, Employee will,
on or before the 15th day of each month of eligibility for continued payments, submit to
Company a written description of the ongoing efforts Employee has made to obtain replacement
employment, including (i) identifying by name and address all prospective employers to whom
Employee has applied for or inquired about employment, (ii) identifying employment positions sought
or applied for with each listed employer, (iii) affirming that Employee has not received any offers
of employment, (iv) describing all other efforts Employee has made to obtain replacement employment
(the “employment search documentation”); and (v) if replacement employment has been
obtained, the nature of the replacement employment, including the name of employer and position,
the compensation terms of such replacement employment and the date such replacement employment
commenced or will commence. If Employee has obtained replacement employment but is seeking payment
for the difference between the monthly compensation with respect to the replacement employment and
the monthly base pay as was in effect at the time of termination of employment with Company,
Employee shall submit to Company, in addition to the employment search documentation, payroll
records (as well as any other records reasonably requested by Company) showing all compensation
received by Employee from the replacement employment. If Employee breaches any provision of this
Agreement or fails to satisfy any conditions of this Section 10, Employee shall not be entitled to
receive and Company shall not be obligated to pay any payments under this Section 10. If Employee
breaches any provisions of this Agreement or fails to satisfy any conditions of this Section 10,
Employee agrees that Employee shall still be bound by all of Employee’s obligations under this
Agreement, including, without limitation, the non-competition covenants set forth in Section 8 of
this Agreement. Notwithstanding any of the foregoing provisions of this Section 10, Company
reserves the right to release Employee from Employee’s obligations under Section 8 of this
Agreement at any time during the Non-Competition Period, in full or in sufficient part to allow
Employee to accept employment that would otherwise be prohibited under this Agreement, at which
time Company’s payment obligations under this Section 10 shall cease immediately and Employee shall
not be entitled to any further payments or other compensation. If, as of the date of Employee’s
termination of employment with Company, Employee is a “specified employee” under Section 409A of
the Internal Revenue Code of 1986, as amended (“Code”), to the extent the Non-Competition Period
Payments constitute deferred compensation subject to Code Section 409A, any such Non-Competition
Period Payments otherwise payable during the first six months following Employee’s termination of
employment will be suspended until, and will be payable on, the date that is six months after
Employee’s termination of employment with Company (or, if earlier, the date Employee dies following
termination of employment).

     11. Severability, Modification of Restrictions: The covenants and restrictions in
this Agreement are separate and divisible, and to the extent any clause, portion or section of this
Agreement is determined to be unenforceable or invalid for any reason, Company and Employee
acknowledge and agree that such unenforceability or invalidity shall not affect the enforceability
or validity of the remainder of the Agreement. If any particular covenant, provision or clause of
this Agreement is determined to be unreasonable or unenforceable for any reason, including, without
limitation, the temporal duration, scope of prohibited activity, and/or geographic area

-9-

 

covered by any non-competition, non-solicitation, non-disparagement or non-disclosure
covenant, provision or clause, Company and Employee acknowledge and agree that such covenant,
provision or clause shall automatically be deemed reformed such that the contested covenant,
provision or clause will have the closest effect permitted by applicable law to the original form
and shall be given effect and enforced as so reformed to whatever extent would be reasonable and
enforceable under applicable law. The parties agree that any court interpreting the provisions of
this Agreement shall have the authority, if necessary, to reform any such provision to make it
enforceable under applicable law.

     12. Remedies. Employee acknowledges that a breach or threatened breach by Employee of
this Agreement will give rise to irreparable injury to Company and that money damages will not be
adequate relief for such injury. Accordingly, Employee agrees that Company shall be entitled to
obtain injunctive relief, including, but not limited to, temporary restraining orders, preliminary
injunctions and/or permanent injunctions, without having to post any bond or other security, to
restrain or prohibit such breach or threatened breach, in addition to any other legal remedies
which may be available. In addition to all other relief to which it shall be entitled, Company
shall be entitled to cease all payments to which Employee would otherwise be entitled under Section
10 hereto; continue to enforce this Agreement; recover from Employee all payments made under
Section 10 to the extent attributable to a time during which Employee was in violation of the
covenants for which payment was made; and recover from Employee all litigation costs and attorneys’
fees incurred by Company in any action or proceeding relating to this Agreement in which Company
prevails in any respect, including, but not limited to, any action or proceeding in which Company
seeks enforcement of this Agreement or seeks relief from Employee’s violation of this Agreement.

     13. Survival of Obligations. Employee acknowledges and agrees that Employee’s
obligations under this Agreement, including, without limitation, Employee’s non-disclosure and
non-competition obligations, shall survive the termination of Employee’s employment with Company,
whether or not such termination is with or without cause or whether or not it is voluntary or
involuntary. Employee further acknowledges and agrees that: (a) Employee’s non-disclosure,
non-disparagement, non-solicitation and non-competition covenants set forth in Sections 3 and 8 of
this Agreement shall be construed as independent covenants and that no breach of any contractual or
legal duty by Company shall be held sufficient to excuse or terminate Employee’s obligations under
Sections 3 and 8 of this Agreement or to preclude Company from obtaining injunctive relief or other
remedies for Employee’s violation or threatened violation of such covenants, and (b) the existence
of any claim or cause of action by Employee against Company, whether predicated on this Agreement
or otherwise, shall not constitute a defense to Company’s enforcement of Employee’s obligations
under Sections 3 and 8 of this Agreement.

     14. Governing Law and Choice of Forum. This Agreement shall be construed and enforced
in accordance with the laws of the State of Indiana, notwithstanding any state’s choice-of-law
rules to the contrary. The parties agree that any legal action relating to this Agreement shall be
commenced and maintained exclusively before any appropriate state court located in Kosciusko County
or the United States District Court for the Northern District of Indiana, South Bend Division. The
parties hereby submit to the jurisdiction of such courts and waive any right

-10-

 

to challenge or otherwise object to personal jurisdiction or venue, in any action commenced or
maintained in such courts. Language translations aside, the English version shall govern.

     15. Successors and Assigns. Company shall have the right to assign this Agreement,
and, accordingly, this Agreement shall inure to the benefit of, and may be enforced by, any and all
successors and assigns of Company, including without limitation by asset assignment, stock sale,
merger, consolidation or other corporate reorganization, and shall be binding on Employee,
Employee’s executors, administrators, personal representatives or other successors in interest.
The services to be provided by Employee to Company are personal to the Employee, and Employee shall
not have the right to assign Employee’s duties under this Agreement.

     16. Modification. This Agreement may not be amended, supplemented, or modified except
by a written document signed by both Employee and a duly authorized officer of Company.

     17. No Waiver. The failure of Company to insist in any one or more instances upon
performance of any of the provisions of this Agreement or to pursue its rights hereunder shall not
be construed as a waiver of any such provisions or the relinquishment of any such rights.

     18. Counterparts. This Agreement may be executed in counterparts, each of which shall
be deemed an original, but both of which when taken together will constitute one and the same
agreement.

     19. Entire Agreement. This Agreement, including Recitals, constitutes the entire
agreement of the parties with respect to the subjects specifically addressed herein, and supersedes
any prior agreements, understandings, or representations, oral or written, on the subjects
addressed herein, excluding any change in control severance agreement between Company and Employee.
Notwithstanding the foregoing, to the extent the employee has an existing non-competition,
confidentiality, and/or non-solicitation agreement in favor of Company and has breached or violated
the terms thereof, Company may continue to enforce its rights and remedies under and pursuant to
such existing agreement.

     Employee’s signature below indicates that Employee has read the entire Agreement, Employee
understands what Employee is signing, and is signing it voluntarily. Employee agrees that Company
advised Employee to consult with an attorney prior to signing the Agreement.

-11-

 

“EMPLOYEE”

                                                                

(Employee Signature)

Printed
Name:                                       

Date:                                                       

“COMPANY”

ZIMMER, INC.

By:                                                                

Printed
Name:                                              

Title:                                                             

Date:                                                             

-12-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00161-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00161-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00161-of-00352.parquet"}]]